This is the second wave of warning letters sent to telehealth firms since a crackdown on misleading direct-to-consumer pharmaceutical ads began last September. The FDA has doled out thousands of ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...

BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand names like Ozempi c® and Wegovy® (semaglutide) ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...

A Kentucky lawmaker has filed a new bill that would strengthen oversight of compounded drugs, including weight loss ...

It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that ...

The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...